Diabetes: intensive glucose control reduces complications
The Advance report (action against diabetes and vascular disease) established that intensive glucose control is an effective and safe treatment against type 2 diabetes and that reduces risks of renal disease and other serious complications in a high percentage, sources reportedof the investigation.
The new largest world study results on diabetes treatments were presented at the Congress of the American Diabetes Association (ADA) last Friday and were published in the New England Journal of Medicine.
The study involved a group of independent medical researchers from 20 countries around the world.
11,140 patients with type 2 diabetes participated in the study, who were treated and monitored for five years.
They aimed to reduce 6.5% or below.
Intensive treatment included sulfonylurea, the modified liberation gicazide, for all patients and other drugs that were required to achieve the hemoglobin objective.
"The prevention of the important vascular complications of diabetes requires a multifactorial approach that faces all modifiable risk factors, among which intensive glucose control plays a very important role, particularly protecting the kidneys," he explainedJohn Chalmers, president of the study management group.
Meanwhile, Guillermo Burlando, head of the Department of Medicine of the Tornú Hospital and former president of the Argentine Diabetes Society first highlighted the magnitude of the study.
"It is the first that includes so many diabetic patients that provides solid evidence that strict glycemia control gives very good results and avoids associated serious complications such as kidney disease."
Burlando stressed the importance of the patient knowing the disease thoroughly and that glycemic automation, "the confirmation of the advance results will help so that the patient meets medical treatment, diet and physical activity."
Diabetes mellitus is one of the largest threats to health in populations around the world, where it is currently estimated2025.
